SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)-- #NATUZZI--Natuzzi S.p.A. (NYSE: NTZ) (“Natuzzi” or the “Company”) announced today that Mr. Pietro Labriola has formally accepted the appointment as a non-executive director of the Company by way of co-optation, effective August 6, 2025, further to the resolution adopted by the Board of Directors on July 29, 2025. Mr. Labriola will remain in office until the next Shareholders' Meeting, at which time it will be submitted for confirmation by the shareholders.

NEW PORT RICHEY, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today announced that it has completed its previously announced acquisition of Heliogen, Inc. (“Heliogen”), a provider of on-demand clean energy technology solutions (the “Heliogen transaction”).

SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results for the second quarter ended June 30, 2025, and provided a general business update.

This season, Lulus invites women everywhere to embrace confidence, connection, and style — making every moment a reason to feel unforgettable This season, Lulus invites women everywhere to embrace confidence, connection, and style — making every moment a reason to feel unforgettable

SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, today announced that it will report its Q2 2025 operating results on Thursday, August 14, 2025 after the market closes. Management will host a conference call on Thursday, August 14, 2025 at 4:30 p.m.

DUBLIN--(BUSINESS WIRE)--Dole plc (NYSE: DOLE) ("Dole" or the "Group" or the "Company") today released its financial results for the three and six months ended June 30, 2025. Highlights for the three months ended June 30, 2025: Very strong performance for the second quarter, with growth across all Continuing Operations1 segments Revenue of $2.4 billion, an increase of 14.3% (an increase of 12.1% on a like-for-like basis2) Net Income decreased to $18.0 million, primarily due to a loss in the Fres.

DUBAI, UAE and ISLAMABAD , Aug. 11, 2025 /PRNewswire/ -- NWTN Inc. ("NWTN" or the "Company") (Nasdaq: NWTN), a global smart mobility and manufacturing platform, today executed an Asset Contribution and Share Issuance Agreement (SPA) with Pakistan's prominent industrial group JW Corporation. The agreement grants NWTN exclusive usage rights to JW Corporation's complete knock-down (CKD) automotive assembly facility in Lahore's China-Pakistan Special Economic Zone (JW-SEZ) and access to JW Corporation's nationwide network of over 400 sales outlets in Pakistan.

HONG KONG , Aug. 11, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), today announced the acquisition of a fully operational 50 MW mining facility in Georgia, USA, for a total cash consideration of US$19.5 million – a pivotal step marking the Company's transition into a diverse strategy that manages a robust portfolio of Bitcoin mining and energy infrastructure. This transaction represents Cango's first step to steadily increase its portfolio of owned and operated mining facilities.

STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.

VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced the appointments of Greg Ciongoli and Robert E. Landry to the Company's Board of Directors, effective August 10, 2025. Mr. Ciongoli and Mr. Landry were also appointed as members of the audit committee of the Board of Directors.

HONG KONG , Aug. 11, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), today announced the acquisition of a fully operational 50 MW mining facility in Georgia, USA, for a total cash consideration of US$19.5 million – a pivotal step marking the Company's transition into a diverse strategy that manages a robust portfolio of Bitcoin mining and energy infrastructure. This transaction represents Cango's first step to steadily increase its portfolio of owned and operated mining facilities.

ENGLEWOOD, Colo. , Aug. 11, 2025 /PRNewswire/ -- WOW!

PANAMA CITY , Aug. 11, 2025 /PRNewswire/ -- Banco Latinoamericano de Comercio Exterior, S.A. ("Bladex" or "the Bank"; NYSE: BLX) announced a new issuance of Cebures (Certificados Bursátiles de Largo Plazo) in the Mexican capital markets for a total amount of MXN 4 billion (four billion Mexican pesos).

SANTA CLARA, Calif. , Aug. 11, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced that it will report its second quarter 2025 unaudited financial results after the market closes on Tuesday, August 26, 2025.

Paris, France--(Newsfile Corp. - August 11, 2025) - Sequans Communications S.A. (NYSE: SQNS), a pioneer in adopting Bitcoin as its primary treasury reserve asset and a leading provider of cellular IoT semiconductor solutions, today announced the acquisition of an additional 13 bitcoins for approximately $1.5 million, at an average purchase price of $117,012 per bitcoin, inclusive of fees.

Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands, is pleased to announce that it has secured an exclusive supply agreement with Coca-Cola Canada Bottling Limited ("CCCBL"), a division of Coca-Cola (NYSE: KO) and its over 200 brands and related products to customers around the world. The agreement names Coca-Cola as our preferred beverage partner allowing for all brands in the Happy Belly portfolio to participate in the program.

LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) (“Barrick” or the “Company”) delivered a strong performance in the second quarter, increasing gold and copper production, growing free cash flow1 and advancing its pipeline of Tier One2 projects — all while returning more capital to shareholders. The performance builds on the first quarter's positive start to the year and positions the Company for an even stronger second half.

ATLANTA & NEW YORK--(BUSINESS WIRE)--ICE Mortgage Technology, neutral provider of a robust end-to-end mortgage platform and part of Intercontinental Exchange, Inc. (NYSE: ICE), today released its August 2025 Mortgage Monitor report. ICE data reveals that mortgage originations had their highest quarterly volume since 2022, with both purchase and cash-out refinance activity nearing three-year highs. At the same time, total and tappable home equity volumes were the highest on record. “Homeowners a.

According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to Venofer ® for the treatment of iron deficiency anemia in patients with chronic kidney disease RANCHO CUCAMONGA, CA / ACCESS Newswire / August 11, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), a biopharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, today announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vials, previously referred to as …

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop, Inc. announced today that it has arranged a $160 million loan for a master planned community located in California's acclaimed Coachella Valley in the City of Rancho Mirage. The loan has a $27 million re-advance component for total proceeds of $187 million. Walker & Dunlop Capital Markets, led by Sean Reimer, Aaron Appel, Jonathan Schwartz, Keith Kurland, Adam Schwartz, Dustin Stolly, Ari Hirt, and Christopher de Raet, were exclusive advi.